- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Regenerative Medicine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Regenerative Medicine market size is estimated to be worth US$ 34340 million in 2021 and is forecast to a readjusted size of USD 111830 million by 2028 with a CAGR of 18.4% during review period. Dermatology accounting for % of the Regenerative Medicine global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Cell Therapy segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Regenerative Medicine include J & J (DePuy Synthes), Medtronic, Zimmer Biomet, Stryker, and Allergan(Acelity), etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Regenerative Medicine market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Cell Therapy
Tissue Engineering
Biomaterial
Other
Market segment by Application, can be divided into
Dermatology
Cardiovascular
CNS
Orthopedic
Others
Market segment by players, this report covers
J & J (DePuy Synthes)
Medtronic
Zimmer Biomet
Stryker
Allergan(Acelity)
MiMedx Group
Organogenesis
Fujifilm Cellular Dynamics
Osiris Therapeutics
Vcanbio
CCBC
Cytori
Celgene
Vericel Corporation
Guanhao Biotech
Mesoblast
AMAG Pharmaceuticals (CBR)
ViaCord
CordLife
Integra LifeSciences
Nuvasive
Cook Biotech
Japan Tissue Engineering
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Regenerative Medicine product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Regenerative Medicine, with revenue, gross margin and global market share of Regenerative Medicine from 2019 to 2022.
Chapter 3, the Regenerative Medicine competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Regenerative Medicine market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Regenerative Medicine research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1.1 Product Overview and Scope of Regenerative Medicine
1.2 Classification of Regenerative Medicine by Type
1.2.1 Overview: Global Regenerative Medicine Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Regenerative Medicine Revenue Market Share by Type in 2021
1.2.3 Cell Therapy
1.2.4 Tissue Engineering
1.2.5 Biomaterial
1.2.6 Other
1.3 Global Regenerative Medicine Market by Application
1.3.1 Overview: Global Regenerative Medicine Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Dermatology
1.3.3 Cardiovascular
1.3.4 CNS
1.3.5 Orthopedic
1.3.6 Others
1.4 Global Regenerative Medicine Market Size & Forecast
1.5 Global Regenerative Medicine Market Size and Forecast by Region
1.5.1 Global Regenerative Medicine Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Regenerative Medicine Market Size by Region, (2017-2022)
1.5.3 North America Regenerative Medicine Market Size and Prospect (2017-2028)
1.5.4 Europe Regenerative Medicine Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Regenerative Medicine Market Size and Prospect (2017-2028)
1.5.6 South America Regenerative Medicine Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Regenerative Medicine Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Regenerative Medicine Market Drivers
1.6.2 Regenerative Medicine Market Restraints
1.6.3 Regenerative Medicine Trends Analysis
2 Company Profiles
2.1 J & J (DePuy Synthes)
2.1.1 J & J (DePuy Synthes) Details
2.1.2 J & J (DePuy Synthes) Major Business
2.1.3 J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
2.1.4 J & J (DePuy Synthes) Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 J & J (DePuy Synthes) Recent Developments and Future Plans
2.2 Medtronic
2.2.1 Medtronic Details
2.2.2 Medtronic Major Business
2.2.3 Medtronic Regenerative Medicine Product and Solutions
2.2.4 Medtronic Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Medtronic Recent Developments and Future Plans
2.3 Zimmer Biomet
2.3.1 Zimmer Biomet Details
2.3.2 Zimmer Biomet Major Business
2.3.3 Zimmer Biomet Regenerative Medicine Product and Solutions
2.3.4 Zimmer Biomet Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Zimmer Biomet Recent Developments and Future Plans
2.4 Stryker
2.4.1 Stryker Details
2.4.2 Stryker Major Business
2.4.3 Stryker Regenerative Medicine Product and Solutions
2.4.4 Stryker Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Stryker Recent Developments and Future Plans
2.5 Allergan(Acelity)
2.5.1 Allergan(Acelity) Details
2.5.2 Allergan(Acelity) Major Business
2.5.3 Allergan(Acelity) Regenerative Medicine Product and Solutions
2.5.4 Allergan(Acelity) Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Allergan(Acelity) Recent Developments and Future Plans
2.6 MiMedx Group
2.6.1 MiMedx Group Details
2.6.2 MiMedx Group Major Business
2.6.3 MiMedx Group Regenerative Medicine Product and Solutions
2.6.4 MiMedx Group Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 MiMedx Group Recent Developments and Future Plans
2.7 Organogenesis
2.7.1 Organogenesis Details
2.7.2 Organogenesis Major Business
2.7.3 Organogenesis Regenerative Medicine Product and Solutions
2.7.4 Organogenesis Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Organogenesis Recent Developments and Future Plans
2.8 Fujifilm Cellular Dynamics
2.8.1 Fujifilm Cellular Dynamics Details
2.8.2 Fujifilm Cellular Dynamics Major Business
2.8.3 Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
2.8.4 Fujifilm Cellular Dynamics Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Fujifilm Cellular Dynamics Recent Developments and Future Plans
2.9 Osiris Therapeutics
2.9.1 Osiris Therapeutics Details
2.9.2 Osiris Therapeutics Major Business
2.9.3 Osiris Therapeutics Regenerative Medicine Product and Solutions
2.9.4 Osiris Therapeutics Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Osiris Therapeutics Recent Developments and Future Plans
2.10 Vcanbio
2.10.1 Vcanbio Details
2.10.2 Vcanbio Major Business
2.10.3 Vcanbio Regenerative Medicine Product and Solutions
2.10.4 Vcanbio Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Vcanbio Recent Developments and Future Plans
2.11 CCBC
2.11.1 CCBC Details
2.11.2 CCBC Major Business
2.11.3 CCBC Regenerative Medicine Product and Solutions
2.11.4 CCBC Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 CCBC Recent Developments and Future Plans
2.12 Cytori
2.12.1 Cytori Details
2.12.2 Cytori Major Business
2.12.3 Cytori Regenerative Medicine Product and Solutions
2.12.4 Cytori Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Cytori Recent Developments and Future Plans
2.13 Celgene
2.13.1 Celgene Details
2.13.2 Celgene Major Business
2.13.3 Celgene Regenerative Medicine Product and Solutions
2.13.4 Celgene Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Celgene Recent Developments and Future Plans
2.14 Vericel Corporation
2.14.1 Vericel Corporation Details
2.14.2 Vericel Corporation Major Business
2.14.3 Vericel Corporation Regenerative Medicine Product and Solutions
2.14.4 Vericel Corporation Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.14.5 Vericel Corporation Recent Developments and Future Plans
2.15 Guanhao Biotech
2.15.1 Guanhao Biotech Details
2.15.2 Guanhao Biotech Major Business
2.15.3 Guanhao Biotech Regenerative Medicine Product and Solutions
2.15.4 Guanhao Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.15.5 Guanhao Biotech Recent Developments and Future Plans
2.16 Mesoblast
2.16.1 Mesoblast Details
2.16.2 Mesoblast Major Business
2.16.3 Mesoblast Regenerative Medicine Product and Solutions
2.16.4 Mesoblast Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.16.5 Mesoblast Recent Developments and Future Plans
2.17 AMAG Pharmaceuticals (CBR)
2.17.1 AMAG Pharmaceuticals (CBR) Details
2.17.2 AMAG Pharmaceuticals (CBR) Major Business
2.17.3 AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
2.17.4 AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.17.5 AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
2.18 ViaCord
2.18.1 ViaCord Details
2.18.2 ViaCord Major Business
2.18.3 ViaCord Regenerative Medicine Product and Solutions
2.18.4 ViaCord Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.18.5 ViaCord Recent Developments and Future Plans
2.19 CordLife
2.19.1 CordLife Details
2.19.2 CordLife Major Business
2.19.3 CordLife Regenerative Medicine Product and Solutions
2.19.4 CordLife Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.19.5 CordLife Recent Developments and Future Plans
2.20 Integra LifeSciences
2.20.1 Integra LifeSciences Details
2.20.2 Integra LifeSciences Major Business
2.20.3 Integra LifeSciences Regenerative Medicine Product and Solutions
2.20.4 Integra LifeSciences Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.20.5 Integra LifeSciences Recent Developments and Future Plans
2.21 Nuvasive
2.21.1 Nuvasive Details
2.21.2 Nuvasive Major Business
2.21.3 Nuvasive Regenerative Medicine Product and Solutions
2.21.4 Nuvasive Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.21.5 Nuvasive Recent Developments and Future Plans
2.22 Cook Biotech
2.22.1 Cook Biotech Details
2.22.2 Cook Biotech Major Business
2.22.3 Cook Biotech Regenerative Medicine Product and Solutions
2.22.4 Cook Biotech Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.22.5 Cook Biotech Recent Developments and Future Plans
2.23 Japan Tissue Engineering
2.23.1 Japan Tissue Engineering Details
2.23.2 Japan Tissue Engineering Major Business
2.23.3 Japan Tissue Engineering Regenerative Medicine Product and Solutions
2.23.4 Japan Tissue Engineering Regenerative Medicine Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.23.5 Japan Tissue Engineering Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Regenerative Medicine Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Regenerative Medicine Players Market Share in 2021
3.2.2 Top 10 Regenerative Medicine Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Regenerative Medicine Players Head Office, Products and Services Provided
3.4 Regenerative Medicine Mergers & Acquisitions
3.5 Regenerative Medicine New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Regenerative Medicine Revenue and Market Share by Type (2017-2022)
4.2 Global Regenerative Medicine Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Regenerative Medicine Revenue Market Share by Application (2017-2022)
5.2 Global Regenerative Medicine Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Regenerative Medicine Revenue by Type (2017-2028)
6.2 North America Regenerative Medicine Revenue by Application (2017-2028)
6.3 North America Regenerative Medicine Market Size by Country
6.3.1 North America Regenerative Medicine Revenue by Country (2017-2028)
6.3.2 United States Regenerative Medicine Market Size and Forecast (2017-2028)
6.3.3 Canada Regenerative Medicine Market Size and Forecast (2017-2028)
6.3.4 Mexico Regenerative Medicine Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Regenerative Medicine Revenue by Type (2017-2028)
7.2 Europe Regenerative Medicine Revenue by Application (2017-2028)
7.3 Europe Regenerative Medicine Market Size by Country
7.3.1 Europe Regenerative Medicine Revenue by Country (2017-2028)
7.3.2 Germany Regenerative Medicine Market Size and Forecast (2017-2028)
7.3.3 France Regenerative Medicine Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Regenerative Medicine Market Size and Forecast (2017-2028)
7.3.5 Russia Regenerative Medicine Market Size and Forecast (2017-2028)
7.3.6 Italy Regenerative Medicine Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Regenerative Medicine Revenue by Type (2017-2028)
8.2 Asia-Pacific Regenerative Medicine Revenue by Application (2017-2028)
8.3 Asia-Pacific Regenerative Medicine Market Size by Region
8.3.1 Asia-Pacific Regenerative Medicine Revenue by Region (2017-2028)
8.3.2 China Regenerative Medicine Market Size and Forecast (2017-2028)
8.3.3 Japan Regenerative Medicine Market Size and Forecast (2017-2028)
8.3.4 South Korea Regenerative Medicine Market Size and Forecast (2017-2028)
8.3.5 India Regenerative Medicine Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Regenerative Medicine Market Size and Forecast (2017-2028)
8.3.7 Australia Regenerative Medicine Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Regenerative Medicine Revenue by Type (2017-2028)
9.2 South America Regenerative Medicine Revenue by Application (2017-2028)
9.3 South America Regenerative Medicine Market Size by Country
9.3.1 South America Regenerative Medicine Revenue by Country (2017-2028)
9.3.2 Brazil Regenerative Medicine Market Size and Forecast (2017-2028)
9.3.3 Argentina Regenerative Medicine Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Regenerative Medicine Revenue by Type (2017-2028)
10.2 Middle East & Africa Regenerative Medicine Revenue by Application (2017-2028)
10.3 Middle East & Africa Regenerative Medicine Market Size by Country
10.3.1 Middle East & Africa Regenerative Medicine Revenue by Country (2017-2028)
10.3.2 Turkey Regenerative Medicine Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Regenerative Medicine Market Size and Forecast (2017-2028)
10.3.4 UAE Regenerative Medicine Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Regenerative Medicine Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Regenerative Medicine Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Regenerative Medicine Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Regenerative Medicine Revenue (USD Million) by Region (2017-2022)
Table 5. Global Regenerative Medicine Revenue Market Share by Region (2023-2028)
Table 6. J & J (DePuy Synthes) Corporate Information, Head Office, and Major Competitors
Table 7. J & J (DePuy Synthes) Major Business
Table 8. J & J (DePuy Synthes) Regenerative Medicine Product and Solutions
Table 9. J & J (DePuy Synthes) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Medtronic Corporate Information, Head Office, and Major Competitors
Table 11. Medtronic Major Business
Table 12. Medtronic Regenerative Medicine Product and Solutions
Table 13. Medtronic Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Zimmer Biomet Corporate Information, Head Office, and Major Competitors
Table 15. Zimmer Biomet Major Business
Table 16. Zimmer Biomet Regenerative Medicine Product and Solutions
Table 17. Zimmer Biomet Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Stryker Corporate Information, Head Office, and Major Competitors
Table 19. Stryker Major Business
Table 20. Stryker Regenerative Medicine Product and Solutions
Table 21. Stryker Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Allergan(Acelity) Corporate Information, Head Office, and Major Competitors
Table 23. Allergan(Acelity) Major Business
Table 24. Allergan(Acelity) Regenerative Medicine Product and Solutions
Table 25. Allergan(Acelity) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. MiMedx Group Corporate Information, Head Office, and Major Competitors
Table 27. MiMedx Group Major Business
Table 28. MiMedx Group Regenerative Medicine Product and Solutions
Table 29. MiMedx Group Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Organogenesis Corporate Information, Head Office, and Major Competitors
Table 31. Organogenesis Major Business
Table 32. Organogenesis Regenerative Medicine Product and Solutions
Table 33. Organogenesis Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Fujifilm Cellular Dynamics Corporate Information, Head Office, and Major Competitors
Table 35. Fujifilm Cellular Dynamics Major Business
Table 36. Fujifilm Cellular Dynamics Regenerative Medicine Product and Solutions
Table 37. Fujifilm Cellular Dynamics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Osiris Therapeutics Corporate Information, Head Office, and Major Competitors
Table 39. Osiris Therapeutics Major Business
Table 40. Osiris Therapeutics Regenerative Medicine Product and Solutions
Table 41. Osiris Therapeutics Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Vcanbio Corporate Information, Head Office, and Major Competitors
Table 43. Vcanbio Major Business
Table 44. Vcanbio Regenerative Medicine Product and Solutions
Table 45. Vcanbio Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. CCBC Corporate Information, Head Office, and Major Competitors
Table 47. CCBC Major Business
Table 48. CCBC Regenerative Medicine Product and Solutions
Table 49. CCBC Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Cytori Corporate Information, Head Office, and Major Competitors
Table 51. Cytori Major Business
Table 52. Cytori Regenerative Medicine Product and Solutions
Table 53. Cytori Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Celgene Corporate Information, Head Office, and Major Competitors
Table 55. Celgene Major Business
Table 56. Celgene Regenerative Medicine Product and Solutions
Table 57. Celgene Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Vericel Corporation Corporate Information, Head Office, and Major Competitors
Table 59. Vericel Corporation Major Business
Table 60. Vericel Corporation Regenerative Medicine Product and Solutions
Table 61. Vericel Corporation Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 62. Guanhao Biotech Corporate Information, Head Office, and Major Competitors
Table 63. Guanhao Biotech Major Business
Table 64. Guanhao Biotech Regenerative Medicine Product and Solutions
Table 65. Guanhao Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 66. Mesoblast Corporate Information, Head Office, and Major Competitors
Table 67. Mesoblast Major Business
Table 68. Mesoblast Regenerative Medicine Product and Solutions
Table 69. Mesoblast Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 70. AMAG Pharmaceuticals (CBR) Corporate Information, Head Office, and Major Competitors
Table 71. AMAG Pharmaceuticals (CBR) Major Business
Table 72. AMAG Pharmaceuticals (CBR) Regenerative Medicine Product and Solutions
Table 73. AMAG Pharmaceuticals (CBR) Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 74. ViaCord Corporate Information, Head Office, and Major Competitors
Table 75. ViaCord Major Business
Table 76. ViaCord Regenerative Medicine Product and Solutions
Table 77. ViaCord Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 78. CordLife Corporate Information, Head Office, and Major Competitors
Table 79. CordLife Major Business
Table 80. CordLife Regenerative Medicine Product and Solutions
Table 81. CordLife Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 82. Integra LifeSciences Corporate Information, Head Office, and Major Competitors
Table 83. Integra LifeSciences Major Business
Table 84. Integra LifeSciences Regenerative Medicine Product and Solutions
Table 85. Integra LifeSciences Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 86. Nuvasive Corporate Information, Head Office, and Major Competitors
Table 87. Nuvasive Major Business
Table 88. Nuvasive Regenerative Medicine Product and Solutions
Table 89. Nuvasive Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 90. Cook Biotech Corporate Information, Head Office, and Major Competitors
Table 91. Cook Biotech Major Business
Table 92. Cook Biotech Regenerative Medicine Product and Solutions
Table 93. Cook Biotech Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 94. Japan Tissue Engineering Corporate Information, Head Office, and Major Competitors
Table 95. Japan Tissue Engineering Major Business
Table 96. Japan Tissue Engineering Regenerative Medicine Product and Solutions
Table 97. Japan Tissue Engineering Regenerative Medicine Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 98. Global Regenerative Medicine Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 99. Global Regenerative Medicine Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 100. Breakdown of Regenerative Medicine by Company Type (Tier 1, Tier 2 and Tier 3)
Table 101. Regenerative Medicine Players Head Office, Products and Services Provided
Table 102. Regenerative Medicine Mergers & Acquisitions in the Past Five Years
Table 103. Regenerative Medicine New Entrants and Expansion Plans
Table 104. Global Regenerative Medicine Revenue (USD Million) by Type (2017-2022)
Table 105. Global Regenerative Medicine Revenue Share by Type (2017-2022)
Table 106. Global Regenerative Medicine Revenue Forecast by Type (2023-2028)
Table 107. Global Regenerative Medicine Revenue by Application (2017-2022)
Table 108. Global Regenerative Medicine Revenue Forecast by Application (2023-2028)
Table 109. North America Regenerative Medicine Revenue by Type (2017-2022) & (USD Million)
Table 110. North America Regenerative Medicine Revenue by Type (2023-2028) & (USD Million)
Table 111. North America Regenerative Medicine Revenue by Application (2017-2022) & (USD Million)
Table 112. North America Regenerative Medicine Revenue by Application (2023-2028) & (USD Million)
Table 113. North America Regenerative Medicine Revenue by Country (2017-2022) & (USD Million)
Table 114. North America Regenerative Medicine Revenue by Country (2023-2028) & (USD Million)
Table 115. Europe Regenerative Medicine Revenue by Type (2017-2022) & (USD Million)
Table 116. Europe Regenerative Medicine Revenue by Type (2023-2028) & (USD Million)
Table 117. Europe Regenerative Medicine Revenue by Application (2017-2022) & (USD Million)
Table 118. Europe Regenerative Medicine Revenue by Application (2023-2028) & (USD Million)
Table 119. Europe Regenerative Medicine Revenue by Country (2017-2022) & (USD Million)
Table 120. Europe Regenerative Medicine Revenue by Country (2023-2028) & (USD Million)
Table 121. Asia-Pacific Regenerative Medicine Revenue by Type (2017-2022) & (USD Million)
Table 122. Asia-Pacific Regenerative Medicine Revenue by Type (2023-2028) & (USD Million)
Table 123. Asia-Pacific Regenerative Medicine Revenue by Application (2017-2022) & (USD Million)
Table 124. Asia-Pacific Regenerative Medicine Revenue by Application (2023-2028) & (USD Million)
Table 125. Asia-Pacific Regenerative Medicine Revenue by Region (2017-2022) & (USD Million)
Table 126. Asia-Pacific Regenerative Medicine Revenue by Region (2023-2028) & (USD Million)
Table 127. South America Regenerative Medicine Revenue by Type (2017-2022) & (USD Million)
Table 128. South America Regenerative Medicine Revenue by Type (2023-2028) & (USD Million)
Table 129. South America Regenerative Medicine Revenue by Application (2017-2022) & (USD Million)
Table 130. South America Regenerative Medicine Revenue by Application (2023-2028) & (USD Million)
Table 131. South America Regenerative Medicine Revenue by Country (2017-2022) & (USD Million)
Table 132. South America Regenerative Medicine Revenue by Country (2023-2028) & (USD Million)
Table 133. Middle East & Africa Regenerative Medicine Revenue by Type (2017-2022) & (USD Million)
Table 134. Middle East & Africa Regenerative Medicine Revenue by Type (2023-2028) & (USD Million)
Table 135. Middle East & Africa Regenerative Medicine Revenue by Application (2017-2022) & (USD Million)
Table 136. Middle East & Africa Regenerative Medicine Revenue by Application (2023-2028) & (USD Million)
Table 137. Middle East & Africa Regenerative Medicine Revenue by Country (2017-2022) & (USD Million)
Table 138. Middle East & Africa Regenerative Medicine Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Regenerative Medicine Picture
Figure 2. Global Regenerative Medicine Revenue Market Share by Type in 2021
Figure 3. Cell Therapy
Figure 4. Tissue Engineering
Figure 5. Biomaterial
Figure 6. Other
Figure 7. Regenerative Medicine Revenue Market Share by Application in 2021
Figure 8. Dermatology Picture
Figure 9. Cardiovascular Picture
Figure 10. CNS Picture
Figure 11. Orthopedic Picture
Figure 12. Others Picture
Figure 13. Global Regenerative Medicine Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Regenerative Medicine Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Regenerative Medicine Revenue Market Share by Region (2017-2028)
Figure 16. Global Regenerative Medicine Revenue Market Share by Region in 2021
Figure 17. North America Regenerative Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Regenerative Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Regenerative Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Regenerative Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Regenerative Medicine Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Regenerative Medicine Market Drivers
Figure 23. Regenerative Medicine Market Restraints
Figure 24. Regenerative Medicine Market Trends
Figure 25. J & J (DePuy Synthes) Recent Developments and Future Plans
Figure 26. Medtronic Recent Developments and Future Plans
Figure 27. Zimmer Biomet Recent Developments and Future Plans
Figure 28. Stryker Recent Developments and Future Plans
Figure 29. Allergan(Acelity) Recent Developments and Future Plans
Figure 30. MiMedx Group Recent Developments and Future Plans
Figure 31. Organogenesis Recent Developments and Future Plans
Figure 32. Fujifilm Cellular Dynamics Recent Developments and Future Plans
Figure 33. Osiris Therapeutics Recent Developments and Future Plans
Figure 34. Vcanbio Recent Developments and Future Plans
Figure 35. CCBC Recent Developments and Future Plans
Figure 36. Cytori Recent Developments and Future Plans
Figure 37. Celgene Recent Developments and Future Plans
Figure 38. Vericel Corporation Recent Developments and Future Plans
Figure 39. Guanhao Biotech Recent Developments and Future Plans
Figure 40. Mesoblast Recent Developments and Future Plans
Figure 41. AMAG Pharmaceuticals (CBR) Recent Developments and Future Plans
Figure 42. ViaCord Recent Developments and Future Plans
Figure 43. CordLife Recent Developments and Future Plans
Figure 44. Integra LifeSciences Recent Developments and Future Plans
Figure 45. Nuvasive Recent Developments and Future Plans
Figure 46. Cook Biotech Recent Developments and Future Plans
Figure 47. Japan Tissue Engineering Recent Developments and Future Plans
Figure 48. Global Regenerative Medicine Revenue Share by Players in 2021
Figure 49. Regenerative Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 50. Global Top 3 Players Regenerative Medicine Revenue Market Share in 2021
Figure 51. Global Top 10 Players Regenerative Medicine Revenue Market Share in 2021
Figure 52. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 53. Global Regenerative Medicine Revenue Share by Type in 2021
Figure 54. Global Regenerative Medicine Market Share Forecast by Type (2023-2028)
Figure 55. Global Regenerative Medicine Revenue Share by Application in 2021
Figure 56. Global Regenerative Medicine Market Share Forecast by Application (2023-2028)
Figure 57. North America Regenerative Medicine Sales Market Share by Type (2017-2028)
Figure 58. North America Regenerative Medicine Sales Market Share by Application (2017-2028)
Figure 59. North America Regenerative Medicine Revenue Market Share by Country (2017-2028)
Figure 60. United States Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Canada Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. Mexico Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. Europe Regenerative Medicine Sales Market Share by Type (2017-2028)
Figure 64. Europe Regenerative Medicine Sales Market Share by Application (2017-2028)
Figure 65. Europe Regenerative Medicine Revenue Market Share by Country (2017-2028)
Figure 66. Germany Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. France Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. United Kingdom Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Russia Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Italy Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. Asia-Pacific Regenerative Medicine Sales Market Share by Type (2017-2028)
Figure 72. Asia-Pacific Regenerative Medicine Sales Market Share by Application (2017-2028)
Figure 73. Asia-Pacific Regenerative Medicine Revenue Market Share by Region (2017-2028)
Figure 74. China Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Japan Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 76. South Korea Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 77. India Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 78. Southeast Asia Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Australia Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. South America Regenerative Medicine Sales Market Share by Type (2017-2028)
Figure 81. South America Regenerative Medicine Sales Market Share by Application (2017-2028)
Figure 82. South America Regenerative Medicine Revenue Market Share by Country (2017-2028)
Figure 83. Brazil Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Argentina Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. Middle East and Africa Regenerative Medicine Sales Market Share by Type (2017-2028)
Figure 86. Middle East and Africa Regenerative Medicine Sales Market Share by Application (2017-2028)
Figure 87. Middle East and Africa Regenerative Medicine Revenue Market Share by Country (2017-2028)
Figure 88. Turkey Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 89. Saudi Arabia Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 90. UAE Regenerative Medicine Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 91. Methodology
Figure 92. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
